Back to Cardiology
Cardiologyv2010Evidence-Based

CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk

Calculates the risk of stroke in patients with non-valvular atrial fibrillation, aiding in the decision regarding oral anticoagulation

Clinical Input Parameters

years
Range: 18 — 120 years
Clinical Assessment
Awaiting Parameters
cha2ds2 vasc score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within cardiology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

CHA₂DS₂-VASc = C + H + A₂ + D + S₂ + V + A + Sc

Clinical Pearls & Practice Notes

  • C = Congestive heart failure (1 point)
  • H = Hypertension (1 point)
  • A₂ = Age ≥75 years (2 points), 65-74 years (1 point)
  • D = Diabetes (1 point)
  • S₂ = Previous Stroke/TIA/TE (2 points)
  • V = Vascular disease (1 point)
  • A = Age 65-74 years (1 point)
  • Sc = Sex category female (1 point)
  • DOACs include: dabigatran, rivaroxaban, apixaban, edoxaban
  • Consider HAS-BLED score to assess bleeding risk before initiating anticoagulation

Evidence & Literature Citations

  1. Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263-72.
  2. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. Circulation. 2019;140(2):e125-e151.
  3. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation. Eur Heart J. 2021;42(5):373-498.

Score Interpretation Ranges

Very Low Risk0 – 0 pts

Annual stroke risk: 0.3%

Low Risk1 – 1 pts

Annual stroke risk: 0.9%

Moderate Risk2 – 2 pts

Annual stroke risk: 2.9%

Moderate-High Risk3 – 3 pts

Annual stroke risk: 4.6%

High Risk4 – 4 pts

Annual stroke risk: 6.7%

High Risk5 – 5 pts

Annual stroke risk: 10.0%

Very High Risk6 – 6 pts

Annual stroke risk: 13.6%

Extreme Risk7 – 9 pts

Annual stroke risk: >15%

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.